CEREPHARMA SA of Ath-Ghislenghien at MEDICA 2019 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option


Rue des Journaliers 15, 7822 Ath-Ghislenghien

This company is co-exhibitor of
AWEX - Wallonia Export & Investment

Hall map

MEDICA 2019 hall map (Hall 15): stand B16

Fairground map

MEDICA 2019 fairground map: Hall 15

Our range of products

Product categories

  • 05  Commodities and Consumer Goods
  • 05.15  Wound care equipment
  • 05.15.08  Instant wound dressings

Instant wound dressings

About us

Company details

CEREPHARMA is a young, innovative, and decision-making research and production company. It brings together our top co-workers to focus on major fundamental research issues, leading to strategic and operational decisions.

To maximize new opportunities in our research field, and bring more innovative formulations to the physicians, CEREPHARMA has choosen for a vertical integration of its organization. The Pharma Research & Development Group focuses on the discovery new actives and related modalities; and the Formulation Research & Development Group focuses on formulation, to bring the actives in a performant way into the skin.

CEREPHARMA has also developed an enhanced medical operating structure. Our Company has several diverse skin care opportunities: Primary Skin Care, Specialty Skin Care, Oncology, Surgical Skin Care, Hair Care, Consumer Healthcare. An executive leads each of these fields with clear accountability for performance - from product development through to the product's life on the market. The programs are provided with the resources to achieve attractive growth opportunities and to deliver benefits to all who rely on modern skin care. 

CEREPHARMA offers also a service to launch your private label cosmetic products onto the market. Our skilled experts are involved in each of these projects, this to satisfy all customers requirements. Formulas may be provided by the client or can be developed in our Formulation R&D Unit. 

Our young and strong structure enabels us to react rapidely to opportunities, advance our ideas by an increasing support of our new formulations, and thus forging partnerships with our physicians.

CEREPHARMA is investing in new technologies to add value to its core product offerings.

More Less